Methods of treating fragile x syndrome using pde4 inhibitors
TW202633637APending Publication Date: 2026-08-16DART NEUROSCIENCE LLC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114143927
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-09-10
- Filing Date
- 2025-11-11
- Publication Date
- 2026-08-16
Smart Images
Figure TWG2TA001072965_001 
Figure TWG2TA001072965_002 
Figure TWG2TA001072965_003
Abstract
The present disclosure relates to methods of treating fragile X syndrome (or related symptoms or conditions) using 5-{[5-(3-chlorophenyl)-6-methoxypyridin-3-yl]methyl}pyrimidin-2-amine, or a pharmaceutically acceptable salt thereof; corresponding doses and dosing schedules; and compositions for use therein.
Need to check novelty before this filing date? Find Prior Art